Condition: Myeloid Malignancy · Acute Myeloid Leukemia · Myelodysplastic Syndromes · Sponsor: University of Rochester
The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.
This description comes directly from the study's public registry record.
Kah Poh Loh, MD · 585-276-4353 · Kahpoh_Loh@URMC.Rochester.edu
Becky Gravenstede · 585-727-4728 · becky_gravenstede@urmc.rochester.edu
Always discuss trial participation with your own doctor first.
| University of Rochester | Rochester, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05875805